NeXagen


Public lists: Eye Health (703)

utilized "combinatorial chemistry" technology to discover lead therapeutic and diagnostic compounds.�MACUGEN, approved for wet age-related macular degeneration, was discovered using this technology. Upon NeXagen's merger with Vestar, Inc., the company also marketed and developed liposomal drug delivery products.

utilized "combinatorial chemistry" technology to discover lead therapeutic and diagnostic compounds.�MACUGEN, approved for wet age-related macular degeneration, was discovered using this technology. Upon NeXagen's merger with Ves...Show all

Company (Alive / Active)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NeXagen $0M Nov 10, 2019
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NeXagen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Thomas McNerney & PartnersVenture CapitalStamford, Connecticut, United StatesOther Investors
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Tweezer Mar 23, 2016 Apr 11, 2017 Patent
Portion of a make-up brush Sep 06, 2016 Apr 04, 2017 Patent
Portion of a make-up brush May 28, 2015 Oct 18, 2016 Patent